Lupin's Stock Sees Positive Growth, Rated 'Buy' by MarketsMOJO

Lupin ., a leading pharmaceutical company in the largecap industry, has seen a positive growth in its stock price on October 11, 2024. The stock has gained 3.14%, closing at Rs 2223.45. This has been reflected in the stock call given by MarketsMOJO, which has rated Lupin's stock as 'Buy'.

The stock is currently trading close to its 52-week high of Rs 2312, with a difference of only 3.71%. Lupin has also outperformed the sector by 2.2% in today's trading session, with a day's high of Rs 2229.4, which is a 3.33% increase from its previous close.

In terms of moving averages, Lupin is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.

Compared to the performance of the Sensex, Lupin has shown a strong 1-day performance of 2.99%, while the Sensex has seen a decline of -0.33%. In the past month, Lupin's stock has also outperformed the Sensex with a 1-month performance of 0.65% compared to the Sensex's -0.22%.

Overall, Lupin's stock has shown a positive growth and has been performing well in the market. With a 'Buy' rating from MarketsMOJO and strong performance in both short-term and long-term moving averages, Lupin is a promising investment in the pharmaceutical industry.